Apollo Hospitals Enterprise Ltd Analyst Rating
based on 29 analysts
79.31%
Buy
10.34%
Hold
10.34%
Sell
Based on 29 analysts offering long term price targets for Apollo Hospitals Enterprise Ltd. An average target of ₹7899.69
Source: S&P Global Market Intelligence
Apollo Hospitals Enterprise Ltd Share analysis
Apollo Hospitals Enterprise Ltd price forecast by 29 analysts
Upside of8.25%
High
₹8702
Target
₹7899.69
Low
₹5700
Apollo Hospitals Enterprise Ltd target price ₹7899.69, a slight upside of 8.25% compared to current price of ₹7251.7. According to 29 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Apollo Hospitals Enterprise Ltd revenue growth forecast
Expected growth rate Q1, FY2026:38.45%
Forecast
Actual
Including amortisation and stock based compensations
Apollo Hospitals Enterprise Ltd EPS growth forecast
EPS estimate Q1, FY2026:120.18%
Forecast
Actual
Source: S&P Global Market Intelligence
Apollo Hospitals Enterprise Ltd Performance
Day's Low
Day's High
₹7,210.05Day's Price Range₹7,389.952 Week's Low
52 Week's High
₹5,284.8552-Week Price Range₹7,545
| Returns % | |
| 1 Month Return | + 8.23 % |
| 3 Month Return | + 2.02 % |
| 1 Year Return | + 33.27 % |
| Market Stats | |
| Previous Close | ₹7,297.55 |
| Open | ₹7,324.80 |
| Volume | 3.49L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,04,062.71Cr |
Apollo Hospitals Enterprise Ltd Key Statistics
| P/E Ratio | 88.69 |
| PEG Ratio | 2.63 |
| Market Cap | ₹1,04,062.71 Cr |
| P/B Ratio | 11.85 |
| EPS | 63.77 |
| Dividend Yield | 0 |
| Sector | Healthcare |
| ROE | 13.81 |
Apollo Hospitals Enterprise Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹1,04,062.71 Cr | 85.28% | 0.65 | ₹917 Cr | ₹19,059 Cr | |
| BUY | ₹1,16,004.52 Cr | 191.31% | 0.53 | ₹1,057 Cr | ₹5,704 Cr | |
| BUY | ₹51,540.99 Cr | 82.67% | 0.54 | ₹645 Cr | ₹7,175 Cr | |
| BUY | ₹26,168.40 Cr | 64.14% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
| BUY | ₹23,314.10 Cr | 39.71% | 0.58 | ₹336 Cr | ₹2,498 Cr |
Apollo Hospitals Enterprise Ltd Mutual Fund Holdings
About Apollo Hospitals Enterprise Ltd
The company's top products include diagnostics, medical care, pharmacy services, and health insurance. Apollo Hospitals Enterprise Ltd. is also known for its popular brands, such as Apollo Pharmacy, Apollo Cradle, Apollo Spectra, Apollo Diagnostics, and Apollo Clinics.
Share Price: ₹7251.70 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹1,04,062.71Cr as of today
Revenue: ₹5,589.30Cr as on September 2024 (Q3 24)
Net Profit: ₹395.70Cr as on September 2024 (Q3 24)
Listing date: 23 May, 1995
Chairperson Name: Shobana Kamineni
| Organisation | Apollo Hospitals Enterprise Ltd |
| Headquarters | Chennai |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Apollo Hospitals Enterprise Ltd
Apollo Hospitals Reports Strong Growth and Strategic Investments - 05 Dec, 2024
Apollo Hospitals achieved a 15% revenue growth to ₹19,059 crore in FY2024, with a 33% increase in profit after tax to ₹898 crore. The company also announced a ₹103 crore stake acquisition in its subsidiary, AHLL, to enhance healthcare services across India.Apollo Hospitals Performs India's First DRG Stimulation Surgery - 28 Nov, 2024
Apollo Cancer Centre in Chennai successfully conducted India's first Dorsal Root Ganglion stimulation surgery, providing immediate pain relief to a patient suffering from chronic pain due to nerve damage. This innovative procedure highlights advancements in pain management and the hospital's commitment to improving patient quality of life.Motilal Oswal Recommends Buy on Apollo Hospitals - 26 Nov, 2024
Motilal Oswal Financial Services has reiterated a buy rating on Apollo Hospitals Enterprise, setting a target price of Rs 8,020, driven by strong financial performance and growth strategies, including bed expansion and new service offerings.Apollo Hospitals Receives Positive Buy Rating - 22 Nov, 2024
Apollo Hospitals Enterprise shows strong growth with a 15.6% YoY revenue increase in Q2FY25. Geojit Financial Services reaffirms a BUY rating with a target of Rs 7,764.Apollo Hospitals Reports Strong Q2 Growth - 18 Nov, 2024
Apollo Hospitals Enterprise Ltd reported a 63% YoY increase in net profit to ₹379 crore for Q2 FY2024, with revenues rising 15% to ₹5,589 crore. EBITDA also grew by 30% to ₹816 crore, reflecting the company's commitment to expanding healthcare access across India.Apollo Hospitals Faces Revenue Challenges, Yet Maintains Growth Outlook - 11 Nov, 2024
Apollo Hospitals Enterprise faces a 15% decline in international patient revenue but reports a recovery in net profit. The company maintains a positive growth outlook with a revised target price of Rs 8,000/share, despite competition in the quick commerce space affecting its delivery services.Apollo Hospitals Reports Strong Q2 Performance - 08 Nov, 2024
Apollo Hospitals Enterprise Ltd. reported a 14.41% increase in net sales for September 2024, with net profit up 25.37%. Analysts raise earnings estimates and set a target price of Rs 8,660, indicating strong growth potential.Apollo Hospitals Reports Strong Q2 Earnings and Expansion Plans - 07 Nov, 2024
Apollo Hospitals shares surged after reporting a 63% YoY increase in Q2 net profit. The company announced a Rs 1,700 crore capex drive and saw a 59% profit surge, leading to a 6% rise in share price to a one-year high.Apollo Hospitals Q2 Profit Surges Exceeding Estimates - 06 Nov, 2024
Apollo Hospitals Enterprise Ltd reported a 59% increase in Q2 net profit to ₹395.7 crore, driven by strong revenue growth of 15% to ₹5,589 crore, outperforming market estimates.
Insights on Apollo Hospitals Enterprise Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 11 quarters, 3.58K Cr → 5.63K Cr (in ₹), with an average increase of 4.4% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 7 quarters, 144.5 Cr → 378.8 Cr (in ₹), with an average increase of 14.4% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, APOLLOHOSP stock has moved up by 0.1%
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 43.92% to 45.37% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Max Healthcare Institute Ltd has given 207.8% return, outperforming this stock by 153.9%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 29.33% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Max Healthcare Institute Ltd has given 79.7% return, outperforming this stock by 49.4%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 14.71% to 12.80% in Sep 2024 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 5.38% to 5.12% in Sep 2024 quarter
Apollo Hospitals Enterprise Ltd Financials
Index Inclusions
Apollo Hospitals Enterprise Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 29.33% | 0.00 | |
| Foreign Institutions | 45.37% | 3.30 | |
| Mutual Funds | 12.8% | ||
| Retail Investors | 5.12% | ||
| Others | 7.38% | 10.84 |
Apollo Hospitals Enterprise Ltd Key Indicators
Apollo Hospitals Enterprise Ltd Valuation
Apollo Hospitals Enterprise Ltd in the last 5 years
Lowest (33.30x)
April 1, 2020
Today (88.69x)
December 19, 2024
Industry (105.00x)
December 19, 2024
Highest (341.36x)
June 29, 2021
Apollo Hospitals Enterprise Ltd Earnings and Dividends
Apollo Hospitals Enterprise Ltd Earnings Results
Apollo Hospitals Enterprise Ltd’s net profit jumped 62.64% since last year same period to ₹378.80Cr in the Q2 2024-2025. On a quarterly growth basis, Apollo Hospitals Enterprise Ltd has generated 24.12% jump in its net profits since last 3-months.
Read More about Earnings ResultsApollo Hospitals Enterprise Ltd Dividends May,2024
In the quarter ending March 2024, Apollo Hospitals Enterprise Ltd has declared dividend of ₹10 - translating a dividend yield of 0.34%.
Read More about Dividends
Apollo Hospitals Enterprise Ltd Technicals Summary
Bearish
Neutral
Bullish
Apollo Hospitals Enterprise Ltd is currently in a Bullish trading position according to technical analysis indicators.
FAQs on Apollo Hospitals Enterprise Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Apollo Hospitals Enterprise Ltd shares.
Apollo Hospitals Enterprise Ltd (APOLLOHOSP) share price today is ₹7251.7
Apollo Hospitals Enterprise Ltd is listed on NSE
Apollo Hospitals Enterprise Ltd is listed on BSE
- Today’s highest price of Apollo Hospitals Enterprise Ltd is ₹7389.9.
- Today’s lowest price of Apollo Hospitals Enterprise Ltd is ₹7210.05.
PE Ratio of Apollo Hospitals Enterprise Ltd is 88.69
PE ratio = Apollo Hospitals Enterprise Ltd Market price per share / Apollo Hospitals Enterprise Ltd Earnings per share
Today’s traded volume of Apollo Hospitals Enterprise Ltd(APOLLOHOSP) is 3.49L.
Today’s market capitalisation of Apollo Hospitals Enterprise Ltd(APOLLOHOSP) is ₹104062.71Cr.
| Apollo Hospitals Enterprise Ltd(APOLLOHOSP | Price |
|---|---|
52 Week High | ₹7545 |
52 Week Low | ₹5284.85 |
Apollo Hospitals Enterprise Ltd(APOLLOHOSP) share price is ₹7251.7. It is down -3.89% from its 52 Week High price of ₹7545
Apollo Hospitals Enterprise Ltd(APOLLOHOSP) share price is ₹7251.7. It is up 37.22% from its 52 Week Low price of ₹5284.85
| Apollo Hospitals Enterprise Ltd(APOLLOHOSP | Returns |
|---|---|
1 Day Returns | -45.85% |
1 Month Returns | 8.23% |
3 Month Returns | 2.02% |
1 Year Returns | 33.27% |